Global New Psychoactive Substance Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “New Psychoactive Substance Industry Forecast” looks at past sales and reviews total world New Psychoactive Substance sales in 2022, providing a comprehensive analysis by region and market sector of projected New Psychoactive Substance sales for 2023 through 2029. With New Psychoactive Substance sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world New Psychoactive Substance industry.
This Insight Report provides a comprehensive analysis of the global New Psychoactive Substance landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on New Psychoactive Substance portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global New Psychoactive Substance market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for New Psychoactive Substance and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global New Psychoactive Substance.
The global New Psychoactive Substance market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for New Psychoactive Substance is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for New Psychoactive Substance is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for New Psychoactive Substance is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key New Psychoactive Substance players cover Zynerba Pharmaceuticals, GW Pharmaceuticals, Teewinot Life Sciences, AusCann, Cannabics Pharmaceuticals, Tilray, Cyrelian, Anandia Laboratories and InMed Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of New Psychoactive Substance market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “New Psychoactive Substance Industry Forecast” looks at past sales and reviews total world New Psychoactive Substance sales in 2022, providing a comprehensive analysis by region and market sector of projected New Psychoactive Substance sales for 2023 through 2029. With New Psychoactive Substance sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world New Psychoactive Substance industry.
This Insight Report provides a comprehensive analysis of the global New Psychoactive Substance landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on New Psychoactive Substance portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global New Psychoactive Substance market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for New Psychoactive Substance and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global New Psychoactive Substance.
The global New Psychoactive Substance market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for New Psychoactive Substance is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for New Psychoactive Substance is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for New Psychoactive Substance is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key New Psychoactive Substance players cover Zynerba Pharmaceuticals, GW Pharmaceuticals, Teewinot Life Sciences, AusCann, Cannabics Pharmaceuticals, Tilray, Cyrelian, Anandia Laboratories and InMed Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of New Psychoactive Substance market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Stimulants
- Cannabinoids
- Hallucinogens
- Depressants
- Cancer
- Neuropathic Disorders
- Spasticity
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zynerba Pharmaceuticals
- GW Pharmaceuticals
- Teewinot Life Sciences
- AusCann
- Cannabics Pharmaceuticals
- Tilray
- Cyrelian
- Anandia Laboratories
- InMed Pharmaceuticals
- Renew Biopharma
- Cronos Group
- ICC International Cannabis
- Biotii Technologies
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global New Psychoactive Substance Market Size 2018-2029
2.1.2 New Psychoactive Substance Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 New Psychoactive Substance Segment by Type
2.2.1 Stimulants
2.2.2 Cannabinoids
2.2.3 Hallucinogens
2.2.4 Depressants
2.3 New Psychoactive Substance Market Size by Type
2.3.1 New Psychoactive Substance Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global New Psychoactive Substance Market Size Market Share by Type (2018-2023)
2.4 New Psychoactive Substance Segment by Application
2.4.1 Cancer
2.4.2 Neuropathic Disorders
2.4.3 Spasticity
2.4.4 Others
2.5 New Psychoactive Substance Market Size by Application
2.5.1 New Psychoactive Substance Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global New Psychoactive Substance Market Size Market Share by Application (2018-2023)
3 NEW PSYCHOACTIVE SUBSTANCE MARKET SIZE BY PLAYER
3.1 New Psychoactive Substance Market Size Market Share by Players
3.1.1 Global New Psychoactive Substance Revenue by Players (2018-2023)
3.1.2 Global New Psychoactive Substance Revenue Market Share by Players (2018-2023)
3.2 Global New Psychoactive Substance Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEW PSYCHOACTIVE SUBSTANCE BY REGIONS
4.1 New Psychoactive Substance Market Size by Regions (2018-2023)
4.2 Americas New Psychoactive Substance Market Size Growth (2018-2023)
4.3 APAC New Psychoactive Substance Market Size Growth (2018-2023)
4.4 Europe New Psychoactive Substance Market Size Growth (2018-2023)
4.5 Middle East & Africa New Psychoactive Substance Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas New Psychoactive Substance Market Size by Country (2018-2023)
5.2 Americas New Psychoactive Substance Market Size by Type (2018-2023)
5.3 Americas New Psychoactive Substance Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC New Psychoactive Substance Market Size by Region (2018-2023)
6.2 APAC New Psychoactive Substance Market Size by Type (2018-2023)
6.3 APAC New Psychoactive Substance Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe New Psychoactive Substance by Country (2018-2023)
7.2 Europe New Psychoactive Substance Market Size by Type (2018-2023)
7.3 Europe New Psychoactive Substance Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa New Psychoactive Substance by Region (2018-2023)
8.2 Middle East & Africa New Psychoactive Substance Market Size by Type (2018-2023)
8.3 Middle East & Africa New Psychoactive Substance Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEW PSYCHOACTIVE SUBSTANCE MARKET FORECAST
10.1 Global New Psychoactive Substance Forecast by Regions (2024-2029)
10.1.1 Global New Psychoactive Substance Forecast by Regions (2024-2029)
10.1.2 Americas New Psychoactive Substance Forecast
10.1.3 APAC New Psychoactive Substance Forecast
10.1.4 Europe New Psychoactive Substance Forecast
10.1.5 Middle East & Africa New Psychoactive Substance Forecast
10.2 Americas New Psychoactive Substance Forecast by Country (2024-2029)
10.2.1 United States New Psychoactive Substance Market Forecast
10.2.2 Canada New Psychoactive Substance Market Forecast
10.2.3 Mexico New Psychoactive Substance Market Forecast
10.2.4 Brazil New Psychoactive Substance Market Forecast
10.3 APAC New Psychoactive Substance Forecast by Region (2024-2029)
10.3.1 China New Psychoactive Substance Market Forecast
10.3.2 Japan New Psychoactive Substance Market Forecast
10.3.3 Korea New Psychoactive Substance Market Forecast
10.3.4 Southeast Asia New Psychoactive Substance Market Forecast
10.3.5 India New Psychoactive Substance Market Forecast
10.3.6 Australia New Psychoactive Substance Market Forecast
10.4 Europe New Psychoactive Substance Forecast by Country (2024-2029)
10.4.1 Germany New Psychoactive Substance Market Forecast
10.4.2 France New Psychoactive Substance Market Forecast
10.4.3 UK New Psychoactive Substance Market Forecast
10.4.4 Italy New Psychoactive Substance Market Forecast
10.4.5 Russia New Psychoactive Substance Market Forecast
10.5 Middle East & Africa New Psychoactive Substance Forecast by Region (2024-2029)
10.5.1 Egypt New Psychoactive Substance Market Forecast
10.5.2 South Africa New Psychoactive Substance Market Forecast
10.5.3 Israel New Psychoactive Substance Market Forecast
10.5.4 Turkey New Psychoactive Substance Market Forecast
10.5.5 GCC Countries New Psychoactive Substance Market Forecast
10.6 Global New Psychoactive Substance Forecast by Type (2024-2029)
10.7 Global New Psychoactive Substance Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Zynerba Pharmaceuticals
11.1.1 Zynerba Pharmaceuticals Company Information
11.1.2 Zynerba Pharmaceuticals New Psychoactive Substance Product Offered
11.1.3 Zynerba Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Zynerba Pharmaceuticals Main Business Overview
11.1.5 Zynerba Pharmaceuticals Latest Developments
11.2 GW Pharmaceuticals
11.2.1 GW Pharmaceuticals Company Information
11.2.2 GW Pharmaceuticals New Psychoactive Substance Product Offered
11.2.3 GW Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 GW Pharmaceuticals Main Business Overview
11.2.5 GW Pharmaceuticals Latest Developments
11.3 Teewinot Life Sciences
11.3.1 Teewinot Life Sciences Company Information
11.3.2 Teewinot Life Sciences New Psychoactive Substance Product Offered
11.3.3 Teewinot Life Sciences New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Teewinot Life Sciences Main Business Overview
11.3.5 Teewinot Life Sciences Latest Developments
11.4 AusCann
11.4.1 AusCann Company Information
11.4.2 AusCann New Psychoactive Substance Product Offered
11.4.3 AusCann New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 AusCann Main Business Overview
11.4.5 AusCann Latest Developments
11.5 Cannabics Pharmaceuticals
11.5.1 Cannabics Pharmaceuticals Company Information
11.5.2 Cannabics Pharmaceuticals New Psychoactive Substance Product Offered
11.5.3 Cannabics Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Cannabics Pharmaceuticals Main Business Overview
11.5.5 Cannabics Pharmaceuticals Latest Developments
11.6 Tilray
11.6.1 Tilray Company Information
11.6.2 Tilray New Psychoactive Substance Product Offered
11.6.3 Tilray New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Tilray Main Business Overview
11.6.5 Tilray Latest Developments
11.7 Cyrelian
11.7.1 Cyrelian Company Information
11.7.2 Cyrelian New Psychoactive Substance Product Offered
11.7.3 Cyrelian New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Cyrelian Main Business Overview
11.7.5 Cyrelian Latest Developments
11.8 Anandia Laboratories
11.8.1 Anandia Laboratories Company Information
11.8.2 Anandia Laboratories New Psychoactive Substance Product Offered
11.8.3 Anandia Laboratories New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Anandia Laboratories Main Business Overview
11.8.5 Anandia Laboratories Latest Developments
11.9 InMed Pharmaceuticals
11.9.1 InMed Pharmaceuticals Company Information
11.9.2 InMed Pharmaceuticals New Psychoactive Substance Product Offered
11.9.3 InMed Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 InMed Pharmaceuticals Main Business Overview
11.9.5 InMed Pharmaceuticals Latest Developments
11.10 Renew Biopharma
11.10.1 Renew Biopharma Company Information
11.10.2 Renew Biopharma New Psychoactive Substance Product Offered
11.10.3 Renew Biopharma New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Renew Biopharma Main Business Overview
11.10.5 Renew Biopharma Latest Developments
11.11 Cronos Group
11.11.1 Cronos Group Company Information
11.11.2 Cronos Group New Psychoactive Substance Product Offered
11.11.3 Cronos Group New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Cronos Group Main Business Overview
11.11.5 Cronos Group Latest Developments
11.12 ICC International Cannabis
11.12.1 ICC International Cannabis Company Information
11.12.2 ICC International Cannabis New Psychoactive Substance Product Offered
11.12.3 ICC International Cannabis New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 ICC International Cannabis Main Business Overview
11.12.5 ICC International Cannabis Latest Developments
11.13 Biotii Technologies
11.13.1 Biotii Technologies Company Information
11.13.2 Biotii Technologies New Psychoactive Substance Product Offered
11.13.3 Biotii Technologies New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Biotii Technologies Main Business Overview
11.13.5 Biotii Technologies Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global New Psychoactive Substance Market Size 2018-2029
2.1.2 New Psychoactive Substance Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 New Psychoactive Substance Segment by Type
2.2.1 Stimulants
2.2.2 Cannabinoids
2.2.3 Hallucinogens
2.2.4 Depressants
2.3 New Psychoactive Substance Market Size by Type
2.3.1 New Psychoactive Substance Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global New Psychoactive Substance Market Size Market Share by Type (2018-2023)
2.4 New Psychoactive Substance Segment by Application
2.4.1 Cancer
2.4.2 Neuropathic Disorders
2.4.3 Spasticity
2.4.4 Others
2.5 New Psychoactive Substance Market Size by Application
2.5.1 New Psychoactive Substance Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global New Psychoactive Substance Market Size Market Share by Application (2018-2023)
3 NEW PSYCHOACTIVE SUBSTANCE MARKET SIZE BY PLAYER
3.1 New Psychoactive Substance Market Size Market Share by Players
3.1.1 Global New Psychoactive Substance Revenue by Players (2018-2023)
3.1.2 Global New Psychoactive Substance Revenue Market Share by Players (2018-2023)
3.2 Global New Psychoactive Substance Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEW PSYCHOACTIVE SUBSTANCE BY REGIONS
4.1 New Psychoactive Substance Market Size by Regions (2018-2023)
4.2 Americas New Psychoactive Substance Market Size Growth (2018-2023)
4.3 APAC New Psychoactive Substance Market Size Growth (2018-2023)
4.4 Europe New Psychoactive Substance Market Size Growth (2018-2023)
4.5 Middle East & Africa New Psychoactive Substance Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas New Psychoactive Substance Market Size by Country (2018-2023)
5.2 Americas New Psychoactive Substance Market Size by Type (2018-2023)
5.3 Americas New Psychoactive Substance Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC New Psychoactive Substance Market Size by Region (2018-2023)
6.2 APAC New Psychoactive Substance Market Size by Type (2018-2023)
6.3 APAC New Psychoactive Substance Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe New Psychoactive Substance by Country (2018-2023)
7.2 Europe New Psychoactive Substance Market Size by Type (2018-2023)
7.3 Europe New Psychoactive Substance Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa New Psychoactive Substance by Region (2018-2023)
8.2 Middle East & Africa New Psychoactive Substance Market Size by Type (2018-2023)
8.3 Middle East & Africa New Psychoactive Substance Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEW PSYCHOACTIVE SUBSTANCE MARKET FORECAST
10.1 Global New Psychoactive Substance Forecast by Regions (2024-2029)
10.1.1 Global New Psychoactive Substance Forecast by Regions (2024-2029)
10.1.2 Americas New Psychoactive Substance Forecast
10.1.3 APAC New Psychoactive Substance Forecast
10.1.4 Europe New Psychoactive Substance Forecast
10.1.5 Middle East & Africa New Psychoactive Substance Forecast
10.2 Americas New Psychoactive Substance Forecast by Country (2024-2029)
10.2.1 United States New Psychoactive Substance Market Forecast
10.2.2 Canada New Psychoactive Substance Market Forecast
10.2.3 Mexico New Psychoactive Substance Market Forecast
10.2.4 Brazil New Psychoactive Substance Market Forecast
10.3 APAC New Psychoactive Substance Forecast by Region (2024-2029)
10.3.1 China New Psychoactive Substance Market Forecast
10.3.2 Japan New Psychoactive Substance Market Forecast
10.3.3 Korea New Psychoactive Substance Market Forecast
10.3.4 Southeast Asia New Psychoactive Substance Market Forecast
10.3.5 India New Psychoactive Substance Market Forecast
10.3.6 Australia New Psychoactive Substance Market Forecast
10.4 Europe New Psychoactive Substance Forecast by Country (2024-2029)
10.4.1 Germany New Psychoactive Substance Market Forecast
10.4.2 France New Psychoactive Substance Market Forecast
10.4.3 UK New Psychoactive Substance Market Forecast
10.4.4 Italy New Psychoactive Substance Market Forecast
10.4.5 Russia New Psychoactive Substance Market Forecast
10.5 Middle East & Africa New Psychoactive Substance Forecast by Region (2024-2029)
10.5.1 Egypt New Psychoactive Substance Market Forecast
10.5.2 South Africa New Psychoactive Substance Market Forecast
10.5.3 Israel New Psychoactive Substance Market Forecast
10.5.4 Turkey New Psychoactive Substance Market Forecast
10.5.5 GCC Countries New Psychoactive Substance Market Forecast
10.6 Global New Psychoactive Substance Forecast by Type (2024-2029)
10.7 Global New Psychoactive Substance Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Zynerba Pharmaceuticals
11.1.1 Zynerba Pharmaceuticals Company Information
11.1.2 Zynerba Pharmaceuticals New Psychoactive Substance Product Offered
11.1.3 Zynerba Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Zynerba Pharmaceuticals Main Business Overview
11.1.5 Zynerba Pharmaceuticals Latest Developments
11.2 GW Pharmaceuticals
11.2.1 GW Pharmaceuticals Company Information
11.2.2 GW Pharmaceuticals New Psychoactive Substance Product Offered
11.2.3 GW Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 GW Pharmaceuticals Main Business Overview
11.2.5 GW Pharmaceuticals Latest Developments
11.3 Teewinot Life Sciences
11.3.1 Teewinot Life Sciences Company Information
11.3.2 Teewinot Life Sciences New Psychoactive Substance Product Offered
11.3.3 Teewinot Life Sciences New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Teewinot Life Sciences Main Business Overview
11.3.5 Teewinot Life Sciences Latest Developments
11.4 AusCann
11.4.1 AusCann Company Information
11.4.2 AusCann New Psychoactive Substance Product Offered
11.4.3 AusCann New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 AusCann Main Business Overview
11.4.5 AusCann Latest Developments
11.5 Cannabics Pharmaceuticals
11.5.1 Cannabics Pharmaceuticals Company Information
11.5.2 Cannabics Pharmaceuticals New Psychoactive Substance Product Offered
11.5.3 Cannabics Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Cannabics Pharmaceuticals Main Business Overview
11.5.5 Cannabics Pharmaceuticals Latest Developments
11.6 Tilray
11.6.1 Tilray Company Information
11.6.2 Tilray New Psychoactive Substance Product Offered
11.6.3 Tilray New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Tilray Main Business Overview
11.6.5 Tilray Latest Developments
11.7 Cyrelian
11.7.1 Cyrelian Company Information
11.7.2 Cyrelian New Psychoactive Substance Product Offered
11.7.3 Cyrelian New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Cyrelian Main Business Overview
11.7.5 Cyrelian Latest Developments
11.8 Anandia Laboratories
11.8.1 Anandia Laboratories Company Information
11.8.2 Anandia Laboratories New Psychoactive Substance Product Offered
11.8.3 Anandia Laboratories New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Anandia Laboratories Main Business Overview
11.8.5 Anandia Laboratories Latest Developments
11.9 InMed Pharmaceuticals
11.9.1 InMed Pharmaceuticals Company Information
11.9.2 InMed Pharmaceuticals New Psychoactive Substance Product Offered
11.9.3 InMed Pharmaceuticals New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 InMed Pharmaceuticals Main Business Overview
11.9.5 InMed Pharmaceuticals Latest Developments
11.10 Renew Biopharma
11.10.1 Renew Biopharma Company Information
11.10.2 Renew Biopharma New Psychoactive Substance Product Offered
11.10.3 Renew Biopharma New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Renew Biopharma Main Business Overview
11.10.5 Renew Biopharma Latest Developments
11.11 Cronos Group
11.11.1 Cronos Group Company Information
11.11.2 Cronos Group New Psychoactive Substance Product Offered
11.11.3 Cronos Group New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Cronos Group Main Business Overview
11.11.5 Cronos Group Latest Developments
11.12 ICC International Cannabis
11.12.1 ICC International Cannabis Company Information
11.12.2 ICC International Cannabis New Psychoactive Substance Product Offered
11.12.3 ICC International Cannabis New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 ICC International Cannabis Main Business Overview
11.12.5 ICC International Cannabis Latest Developments
11.13 Biotii Technologies
11.13.1 Biotii Technologies Company Information
11.13.2 Biotii Technologies New Psychoactive Substance Product Offered
11.13.3 Biotii Technologies New Psychoactive Substance Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Biotii Technologies Main Business Overview
11.13.5 Biotii Technologies Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. New Psychoactive Substance Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Stimulants
Table 3. Major Players of Cannabinoids
Table 4. Major Players of Hallucinogens
Table 5. Major Players of Depressants
Table 6. New Psychoactive Substance Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global New Psychoactive Substance Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global New Psychoactive Substance Market Size Market Share by Type (2018-2023)
Table 9. New Psychoactive Substance Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global New Psychoactive Substance Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global New Psychoactive Substance Market Size Market Share by Application (2018-2023)
Table 12. Global New Psychoactive Substance Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global New Psychoactive Substance Revenue Market Share by Player (2018-2023)
Table 14. New Psychoactive Substance Key Players Head office and Products Offered
Table 15. New Psychoactive Substance Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global New Psychoactive Substance Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global New Psychoactive Substance Market Size Market Share by Regions (2018-2023)
Table 20. Global New Psychoactive Substance Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global New Psychoactive Substance Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas New Psychoactive Substance Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas New Psychoactive Substance Market Size Market Share by Country (2018-2023)
Table 24. Americas New Psychoactive Substance Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas New Psychoactive Substance Market Size Market Share by Type (2018-2023)
Table 26. Americas New Psychoactive Substance Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas New Psychoactive Substance Market Size Market Share by Application (2018-2023)
Table 28. APAC New Psychoactive Substance Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC New Psychoactive Substance Market Size Market Share by Region (2018-2023)
Table 30. APAC New Psychoactive Substance Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC New Psychoactive Substance Market Size Market Share by Type (2018-2023)
Table 32. APAC New Psychoactive Substance Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC New Psychoactive Substance Market Size Market Share by Application (2018-2023)
Table 34. Europe New Psychoactive Substance Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe New Psychoactive Substance Market Size Market Share by Country (2018-2023)
Table 36. Europe New Psychoactive Substance Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe New Psychoactive Substance Market Size Market Share by Type (2018-2023)
Table 38. Europe New Psychoactive Substance Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe New Psychoactive Substance Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa New Psychoactive Substance Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa New Psychoactive Substance Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa New Psychoactive Substance Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa New Psychoactive Substance Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa New Psychoactive Substance Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa New Psychoactive Substance Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of New Psychoactive Substance
Table 47. Key Market Challenges & Risks of New Psychoactive Substance
Table 48. Key Industry Trends of New Psychoactive Substance
Table 49. Global New Psychoactive Substance Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global New Psychoactive Substance Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global New Psychoactive Substance Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global New Psychoactive Substance Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Zynerba Pharmaceuticals Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 54. Zynerba Pharmaceuticals New Psychoactive Substance Product Offered
Table 55. Zynerba Pharmaceuticals New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Zynerba Pharmaceuticals Main Business
Table 57. Zynerba Pharmaceuticals Latest Developments
Table 58. GW Pharmaceuticals Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 59. GW Pharmaceuticals New Psychoactive Substance Product Offered
Table 60. GW Pharmaceuticals Main Business
Table 61. GW Pharmaceuticals New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. GW Pharmaceuticals Latest Developments
Table 63. Teewinot Life Sciences Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 64. Teewinot Life Sciences New Psychoactive Substance Product Offered
Table 65. Teewinot Life Sciences Main Business
Table 66. Teewinot Life Sciences New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Teewinot Life Sciences Latest Developments
Table 68. AusCann Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 69. AusCann New Psychoactive Substance Product Offered
Table 70. AusCann Main Business
Table 71. AusCann New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. AusCann Latest Developments
Table 73. Cannabics Pharmaceuticals Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 74. Cannabics Pharmaceuticals New Psychoactive Substance Product Offered
Table 75. Cannabics Pharmaceuticals Main Business
Table 76. Cannabics Pharmaceuticals New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Cannabics Pharmaceuticals Latest Developments
Table 78. Tilray Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 79. Tilray New Psychoactive Substance Product Offered
Table 80. Tilray Main Business
Table 81. Tilray New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Tilray Latest Developments
Table 83. Cyrelian Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 84. Cyrelian New Psychoactive Substance Product Offered
Table 85. Cyrelian Main Business
Table 86. Cyrelian New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Cyrelian Latest Developments
Table 88. Anandia Laboratories Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 89. Anandia Laboratories New Psychoactive Substance Product Offered
Table 90. Anandia Laboratories Main Business
Table 91. Anandia Laboratories New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Anandia Laboratories Latest Developments
Table 93. InMed Pharmaceuticals Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 94. InMed Pharmaceuticals New Psychoactive Substance Product Offered
Table 95. InMed Pharmaceuticals Main Business
Table 96. InMed Pharmaceuticals New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. InMed Pharmaceuticals Latest Developments
Table 98. Renew Biopharma Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 99. Renew Biopharma New Psychoactive Substance Product Offered
Table 100. Renew Biopharma Main Business
Table 101. Renew Biopharma New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Renew Biopharma Latest Developments
Table 103. Cronos Group Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 104. Cronos Group New Psychoactive Substance Product Offered
Table 105. Cronos Group New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Cronos Group Main Business
Table 107. Cronos Group Latest Developments
Table 108. ICC International Cannabis Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 109. ICC International Cannabis New Psychoactive Substance Product Offered
Table 110. ICC International Cannabis Main Business
Table 111. ICC International Cannabis New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. ICC International Cannabis Latest Developments
Table 113. Biotii Technologies Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 114. Biotii Technologies New Psychoactive Substance Product Offered
Table 115. Biotii Technologies Main Business
Table 116. Biotii Technologies New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Biotii Technologies Latest Developments
Table 1. New Psychoactive Substance Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Stimulants
Table 3. Major Players of Cannabinoids
Table 4. Major Players of Hallucinogens
Table 5. Major Players of Depressants
Table 6. New Psychoactive Substance Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global New Psychoactive Substance Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global New Psychoactive Substance Market Size Market Share by Type (2018-2023)
Table 9. New Psychoactive Substance Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global New Psychoactive Substance Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global New Psychoactive Substance Market Size Market Share by Application (2018-2023)
Table 12. Global New Psychoactive Substance Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global New Psychoactive Substance Revenue Market Share by Player (2018-2023)
Table 14. New Psychoactive Substance Key Players Head office and Products Offered
Table 15. New Psychoactive Substance Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global New Psychoactive Substance Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global New Psychoactive Substance Market Size Market Share by Regions (2018-2023)
Table 20. Global New Psychoactive Substance Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global New Psychoactive Substance Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas New Psychoactive Substance Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas New Psychoactive Substance Market Size Market Share by Country (2018-2023)
Table 24. Americas New Psychoactive Substance Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas New Psychoactive Substance Market Size Market Share by Type (2018-2023)
Table 26. Americas New Psychoactive Substance Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas New Psychoactive Substance Market Size Market Share by Application (2018-2023)
Table 28. APAC New Psychoactive Substance Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC New Psychoactive Substance Market Size Market Share by Region (2018-2023)
Table 30. APAC New Psychoactive Substance Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC New Psychoactive Substance Market Size Market Share by Type (2018-2023)
Table 32. APAC New Psychoactive Substance Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC New Psychoactive Substance Market Size Market Share by Application (2018-2023)
Table 34. Europe New Psychoactive Substance Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe New Psychoactive Substance Market Size Market Share by Country (2018-2023)
Table 36. Europe New Psychoactive Substance Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe New Psychoactive Substance Market Size Market Share by Type (2018-2023)
Table 38. Europe New Psychoactive Substance Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe New Psychoactive Substance Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa New Psychoactive Substance Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa New Psychoactive Substance Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa New Psychoactive Substance Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa New Psychoactive Substance Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa New Psychoactive Substance Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa New Psychoactive Substance Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of New Psychoactive Substance
Table 47. Key Market Challenges & Risks of New Psychoactive Substance
Table 48. Key Industry Trends of New Psychoactive Substance
Table 49. Global New Psychoactive Substance Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global New Psychoactive Substance Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global New Psychoactive Substance Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global New Psychoactive Substance Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Zynerba Pharmaceuticals Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 54. Zynerba Pharmaceuticals New Psychoactive Substance Product Offered
Table 55. Zynerba Pharmaceuticals New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Zynerba Pharmaceuticals Main Business
Table 57. Zynerba Pharmaceuticals Latest Developments
Table 58. GW Pharmaceuticals Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 59. GW Pharmaceuticals New Psychoactive Substance Product Offered
Table 60. GW Pharmaceuticals Main Business
Table 61. GW Pharmaceuticals New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. GW Pharmaceuticals Latest Developments
Table 63. Teewinot Life Sciences Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 64. Teewinot Life Sciences New Psychoactive Substance Product Offered
Table 65. Teewinot Life Sciences Main Business
Table 66. Teewinot Life Sciences New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Teewinot Life Sciences Latest Developments
Table 68. AusCann Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 69. AusCann New Psychoactive Substance Product Offered
Table 70. AusCann Main Business
Table 71. AusCann New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. AusCann Latest Developments
Table 73. Cannabics Pharmaceuticals Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 74. Cannabics Pharmaceuticals New Psychoactive Substance Product Offered
Table 75. Cannabics Pharmaceuticals Main Business
Table 76. Cannabics Pharmaceuticals New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Cannabics Pharmaceuticals Latest Developments
Table 78. Tilray Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 79. Tilray New Psychoactive Substance Product Offered
Table 80. Tilray Main Business
Table 81. Tilray New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Tilray Latest Developments
Table 83. Cyrelian Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 84. Cyrelian New Psychoactive Substance Product Offered
Table 85. Cyrelian Main Business
Table 86. Cyrelian New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Cyrelian Latest Developments
Table 88. Anandia Laboratories Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 89. Anandia Laboratories New Psychoactive Substance Product Offered
Table 90. Anandia Laboratories Main Business
Table 91. Anandia Laboratories New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Anandia Laboratories Latest Developments
Table 93. InMed Pharmaceuticals Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 94. InMed Pharmaceuticals New Psychoactive Substance Product Offered
Table 95. InMed Pharmaceuticals Main Business
Table 96. InMed Pharmaceuticals New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. InMed Pharmaceuticals Latest Developments
Table 98. Renew Biopharma Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 99. Renew Biopharma New Psychoactive Substance Product Offered
Table 100. Renew Biopharma Main Business
Table 101. Renew Biopharma New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Renew Biopharma Latest Developments
Table 103. Cronos Group Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 104. Cronos Group New Psychoactive Substance Product Offered
Table 105. Cronos Group New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Cronos Group Main Business
Table 107. Cronos Group Latest Developments
Table 108. ICC International Cannabis Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 109. ICC International Cannabis New Psychoactive Substance Product Offered
Table 110. ICC International Cannabis Main Business
Table 111. ICC International Cannabis New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. ICC International Cannabis Latest Developments
Table 113. Biotii Technologies Details, Company Type, New Psychoactive Substance Area Served and Its Competitors
Table 114. Biotii Technologies New Psychoactive Substance Product Offered
Table 115. Biotii Technologies Main Business
Table 116. Biotii Technologies New Psychoactive Substance Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Biotii Technologies Latest Developments
LIST OF FIGURES
Figure 1. New Psychoactive Substance Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global New Psychoactive Substance Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. New Psychoactive Substance Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. New Psychoactive Substance Sales Market Share by Country/Region (2022)
Figure 8. New Psychoactive Substance Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global New Psychoactive Substance Market Size Market Share by Type in 2022
Figure 10. New Psychoactive Substance in Cancer
Figure 11. Global New Psychoactive Substance Market: Cancer (2018-2023) & ($ Millions)
Figure 12. New Psychoactive Substance in Neuropathic Disorders
Figure 13. Global New Psychoactive Substance Market: Neuropathic Disorders (2018-2023) & ($ Millions)
Figure 14. New Psychoactive Substance in Spasticity
Figure 15. Global New Psychoactive Substance Market: Spasticity (2018-2023) & ($ Millions)
Figure 16. New Psychoactive Substance in Others
Figure 17. Global New Psychoactive Substance Market: Others (2018-2023) & ($ Millions)
Figure 18. Global New Psychoactive Substance Market Size Market Share by Application in 2022
Figure 19. Global New Psychoactive Substance Revenue Market Share by Player in 2022
Figure 20. Global New Psychoactive Substance Market Size Market Share by Regions (2018-2023)
Figure 21. Americas New Psychoactive Substance Market Size 2018-2023 ($ Millions)
Figure 22. APAC New Psychoactive Substance Market Size 2018-2023 ($ Millions)
Figure 23. Europe New Psychoactive Substance Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa New Psychoactive Substance Market Size 2018-2023 ($ Millions)
Figure 25. Americas New Psychoactive Substance Value Market Share by Country in 2022
Figure 26. United States New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC New Psychoactive Substance Market Size Market Share by Region in 2022
Figure 31. APAC New Psychoactive Substance Market Size Market Share by Type in 2022
Figure 32. APAC New Psychoactive Substance Market Size Market Share by Application in 2022
Figure 33. China New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 37. India New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe New Psychoactive Substance Market Size Market Share by Country in 2022
Figure 40. Europe New Psychoactive Substance Market Size Market Share by Type (2018-2023)
Figure 41. Europe New Psychoactive Substance Market Size Market Share by Application (2018-2023)
Figure 42. Germany New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 43. France New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa New Psychoactive Substance Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa New Psychoactive Substance Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa New Psychoactive Substance Market Size Market Share by Application (2018-2023)
Figure 50. Egypt New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 56. APAC New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 57. Europe New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 59. United States New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 60. Canada New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 61. Mexico New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 62. Brazil New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 63. China New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 64. Japan New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 65. Korea New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 67. India New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 68. Australia New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 69. Germany New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 70. France New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 71. UK New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 72. Italy New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 73. Russia New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 74. Spain New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 75. Egypt New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 76. South Africa New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 77. Israel New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 78. Turkey New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 80. Global New Psychoactive Substance Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global New Psychoactive Substance Market Size Market Share Forecast by Application (2024-2029)
Figure 1. New Psychoactive Substance Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global New Psychoactive Substance Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. New Psychoactive Substance Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. New Psychoactive Substance Sales Market Share by Country/Region (2022)
Figure 8. New Psychoactive Substance Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global New Psychoactive Substance Market Size Market Share by Type in 2022
Figure 10. New Psychoactive Substance in Cancer
Figure 11. Global New Psychoactive Substance Market: Cancer (2018-2023) & ($ Millions)
Figure 12. New Psychoactive Substance in Neuropathic Disorders
Figure 13. Global New Psychoactive Substance Market: Neuropathic Disorders (2018-2023) & ($ Millions)
Figure 14. New Psychoactive Substance in Spasticity
Figure 15. Global New Psychoactive Substance Market: Spasticity (2018-2023) & ($ Millions)
Figure 16. New Psychoactive Substance in Others
Figure 17. Global New Psychoactive Substance Market: Others (2018-2023) & ($ Millions)
Figure 18. Global New Psychoactive Substance Market Size Market Share by Application in 2022
Figure 19. Global New Psychoactive Substance Revenue Market Share by Player in 2022
Figure 20. Global New Psychoactive Substance Market Size Market Share by Regions (2018-2023)
Figure 21. Americas New Psychoactive Substance Market Size 2018-2023 ($ Millions)
Figure 22. APAC New Psychoactive Substance Market Size 2018-2023 ($ Millions)
Figure 23. Europe New Psychoactive Substance Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa New Psychoactive Substance Market Size 2018-2023 ($ Millions)
Figure 25. Americas New Psychoactive Substance Value Market Share by Country in 2022
Figure 26. United States New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC New Psychoactive Substance Market Size Market Share by Region in 2022
Figure 31. APAC New Psychoactive Substance Market Size Market Share by Type in 2022
Figure 32. APAC New Psychoactive Substance Market Size Market Share by Application in 2022
Figure 33. China New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 37. India New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe New Psychoactive Substance Market Size Market Share by Country in 2022
Figure 40. Europe New Psychoactive Substance Market Size Market Share by Type (2018-2023)
Figure 41. Europe New Psychoactive Substance Market Size Market Share by Application (2018-2023)
Figure 42. Germany New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 43. France New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa New Psychoactive Substance Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa New Psychoactive Substance Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa New Psychoactive Substance Market Size Market Share by Application (2018-2023)
Figure 50. Egypt New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country New Psychoactive Substance Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 56. APAC New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 57. Europe New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 59. United States New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 60. Canada New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 61. Mexico New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 62. Brazil New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 63. China New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 64. Japan New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 65. Korea New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 67. India New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 68. Australia New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 69. Germany New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 70. France New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 71. UK New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 72. Italy New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 73. Russia New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 74. Spain New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 75. Egypt New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 76. South Africa New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 77. Israel New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 78. Turkey New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries New Psychoactive Substance Market Size 2024-2029 ($ Millions)
Figure 80. Global New Psychoactive Substance Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global New Psychoactive Substance Market Size Market Share Forecast by Application (2024-2029)
